Liofilchem has received clearance from the FDA to market in the United States the Ceftobiprole 0.002-32 MTS™ (MIC Test Strip), a quantitative assay for determining the Minimum Inhibitory Concentration (MIC) of ceftobiprole.

MTS™ BPR can be used to determine the MIC of ceftobiprole against the following microorganisms for which ceftobiprole has been shown to be active clinically and/or in vitro according to the FDA drug approved label:

Escherichia coli

Klebsiella pneumoniae

Staphylococcus aureus (includes methicillin resistant isolates)

Download the product IFU

Ref. 921401 – 10/pack

Ref. 92140 – 30/pack

Ref. 921400 – 100/pack

3 years shelf life

-20/+8°C storage temperature

Ceftobiprole MTS™ is available as in-vitro diagnostic (IVD) device in Europe, USA, Canada and many other countries.

Learn more about MTS™

Check the list of FDA-cleared MTS™